Member Info for Computer909

@pmjh, todays announcement of the approval of the new drugs is part of the ongong RECOVERY trial the nhs has been running since the start of Covid

As they have stated a pause of COPD programme and a focus on COVID, i would think the news of two other drugs being approved in the market, would at least warrant an acknowledgment via RNS

“Our immediate priority is to progress SNG001 as a therapeutic for COVID-19 and, as such, our COPD programme will remain paused. We are, nevertheless, pleased to provide further evidence that supports SNG001 as a potential treatment for COVID-19 through the safety, biomarker, and efficacy data generated from patients in this interim review of the COPD trial”

“don't think they are obliged to report first dosing“

Difference between obligation and respect for investors and market sentiment

Would save 100 people a day, if one of those is your gran you would see it as a miracle

“Initiation of the first SG018 sites has commenced in the UK, with dosing expected to commence imminently. The SG018 trial was deemed an Urgent Public Health study and recognised as a National Priority by the National Institute for Health Research (NIHR) in October 2020.”

With alternative treatment being announced we really need and update, 800 new COVID patients atmitted to hospital in london alone every day, surely we shouldn’t be struggling for numbers?

Sarilumab is a recombinant human monoclonal antibody that specifically binds to interleukin-6 receptors and blocks the activity of pro-inflammatory cytokines.

Tocilizumab - Rheumatoid arthritis treatment

Both are pre-approved treatment for other diseases, Medical staff can get them today, now approved for COvid patient

Another Placing ? If you track the volumes since the last two they haven't even churned through those billions, Which broker is going to want to do another placing with that, looks like a death spiral now, so AP can take it private, which IMO was his plan all along.

"certain corporate restructuring" - Getting rid of the corrupt shower that is the BoD, What a joke, just not very funny

@daveri007 Well that is the million dollar question, take a look at the charts before April 2020 for Mcap prior to covid, there has been some movement with CD4 and food intolerance businesses but they will hopefully start revenue generating in the coming year(s), very little immediate revenue generating, the Covid business should be huge but it doesn’t look like the company can achieve delivery of anything at the moment, Everything riding on the mologic antigen test, but the longer they take the more competition appears, unlikely they will be in a position to take part in the £912m tender now.

Fortress Diagnostics only incorporated in March 2020, a few more of Bojo’s mates

Contract says Self-test, supplier says professional use only, it looks like ODX that are keeping to the rules

Any sales from the “VISITECT® COVID-19 IgM/IgA/IgG” test, surely thats under our control?

Abingdon have also confirmed that whilst the DHSC continues to have first refusal for supplies of the AbC-19TM Rapid Test through a Supply of Goods Contract that extends to 14 February 2021, the UK-RTC is liaising with customers and regulatory authorities across a total of 27 international territories, to allow future use of the product outside of the UK.

First refusal doesn't mean exclusivity?

Let’s remember the “Sorry we are closed” statement on Christmas eve, they only opened yesterday, not as though there is anything pressing like a global pandemic going on ...

@prionce, i have communicated frequently with Colin and Walbrook, my point being that rather than leaving investors to be updated by some random taking photos of boxes through their window, the company should update their investors more often in such a volatile times

@SneakySimon, it would be nice to here from them on what they have been doing

@Bagu55, the Uk government told us they had 30m does of Az vaccine available in September 2019, now we only have 500k to start the rollout with, ODX are unlikely to have stockpiled any uk-rtc tests because they knew without MHRA approval the supply contract could be cancelled

Whilst we all hope and expect ODX are working hard (after their little festive break), lets remember we haven't seen any reported sales for any covid products since the pandemic started, Elisa test was a disaster, uk-rtc test looks to be a disaster , Ce marked in july and only 1m ordered, latest update is they are talking to other territories to investigate opportunities outside the uk, why wasn't this done before now,?, Mologic tech transfer looks to be taking longer than expected. Whilst we have other strings to our bow, CD4 and food intolerances, the major contributor to the SP is currently covid, its the lack of grasping the available opportunities that drives the frustration

Ignoring all the issues that have gone by already, being in the hat on the 15th for this tender https://bidstats.uk/tenders/2020/W53/741867652 has to be achieved or the uk market will be gone and we will need to look elsewhere

Unfortunately looks like AP has destroyed this company, we haven't even been able to churn the 3.7B shares from the last placing, (not even the 2.8B from 23rd November), this just means there are so many shares in play that no one wants we can only see one way this is heading, we have only maintained the 0.12-0.13 level because the broker doesn't want to get burnt with the placing shares. He's been like a vampire for the last couple of years, sucking the lifeblood out of the company bit by bit, unfortunately it looks like he got to greedy the last time and has killed his meal ticket.